PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway

Curcumin has the potential to cure dyslipidemia and nonalcoholic fatty liver disease (NAFLD). However, its therapeutic effects are curbed by poor bioavailability. Our previous work has shown that modification of curcumin with polyethylene glycol (PEG) improves blood concentration and tissue distribu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomed Res Int
Main Authors: Liu, Yu, Cheng, Fei, Luo, Yuxuan, Zhan, Zhu, Hu, Peng, Ren, Hong, Tang, Huadong, Peng, Mingli
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2017
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523402/
https://ncbi.nlm.nih.gov/pubmed/28770225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8234507
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares